Navigation Links
Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
Date:2/4/2008

ATLANTA, Feb. 4 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), http://www.geovax.com, an Atlanta based biotechnology company, announced the addition of company co-founder Dr. Harriet Robinson to its staff as Vice President of Research & Development. Dr. Robinson is known worldwide for her outstanding work on retrovirus biology and development of DNA vaccines with special emphasis on HIV/AIDS.

Significant advances by GeoVax's HIV/AIDS vaccine development program have warranted Dr. Robinson's full time participation. She has been instrumental in GeoVax's success through her HIV/AIDS vaccine development activities while at Emory University and as Chief Scientific Advisor to GeoVax. Dr. Robinson joined GeoVax part time in Nov. 2007 and will become full time Feb. 15, 2008.

By focusing her efforts exclusively at GeoVax, Dr. Robinson intends to speed up the vaccine development and human trial evaluation program required to meet FDA regulatory requirements and future vaccine commercialization efforts.

"Our AIDS vaccine efforts are rapidly moving forward to a new and exciting level and include plans for large Phase 2 human trials in 2008," Dr. Robinson said. "It's important for me to be at GeoVax full time to work with our excellent team in this important effort. It is my conviction that our AIDS vaccine is a prime candidate to be safe and effective in preventing AIDS."

"As a co-founder of GeoVax, Dr. Robinson has been instrumental in the success our company has achieved to date," said Don Hildebrand, President, CEO, and Chairman of GeoVax Labs, Inc. "Her leadership in HIV/AIDS vaccine research is invaluable. We believe her contributions will positively impact the lives of millions of people worldwide."

About Dr. Harriet Robinson:

Dr. Robinson is the inventor of GeoVax's HIV-1 AIDS vaccine technology and co-founder of GeoVax Labs, Inc. She served as Chi
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
2. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
3. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
4. MedicAlert Foundation Joins The Alzheimers Association to Offer MedicAlert(R) + Alzheimers Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies
5. Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination
6. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
7. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
8. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
9. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
10. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
11. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2008)...EAPOLIS, July 22 /- Nonin Medical, a ...tions for more than 20 years, has entered,the clin...y to measure,regional oxygen saturation. Today,s m...continuous monitoring of the regional blood oxygen...esting data and outcomes from an ongoing clinical ...
(Date:7/22/2008)...DA Meeting to Discuss Development Plan Completed S...-FirstCall/ -- Amarin Corporation,plc (NASDAQ: AM... with,officials at the U.S. Food and Drug Administ...elop AMR101 for the treatment of,hypertriglyceride...roceeding to Phase 3 with AMR101 in hypertriglycer...
(Date:7/22/2008)...-of-the-Art PET Study Confirms Tyrima Exhibits Exc...erties - - Results Support Initiation of Pha...N.C., July 22 /- CeNeRx BioPharma,In...cializing innovative,treatments for diseases of th... advance its lead candidate Tyrima(TM) into Phase ...
(Date:7/22/2008)...eoffrey Allan Will Stress the Importance to Patien...cs Approval Pathway, RICHMOND, Va., July 22 /PRNe... a developer of follow-on biologics and biopharmac...D., CEO of Insmed, will present at a,Congressional...e,significant need for establishing an approval pa...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Serum sodium predicts mortality 10 times higher in PAH patients 21781 1Serum sodium predicts mortality 10 times higher in PAH patients 21781 2New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 1New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 2New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 3New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 4New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 5New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 6New Long Term HUMIRA 28R 29 28adalimumab 29 Data Show Up to Seven Year Efficacy with Combination Treatment for Rheumatoid Arthritis 21779 71 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9 11 21776 11 in 8 Lower Manhattan residents had signs of PTSD 2 to 3 years after 9 11 21776 2Membrane complexes take flight 5975 1Membrane complexes take flight 5975 2
(Date:7/25/2008)... firm represents Pickerington man who contracted E... Kroger store , Columbus,...onaheyohioinjurylawyers.com [The Donahey Law Firm... central Ohio, has filed a product liability lawsu...ainst The Kroger Co., in connection with an E. col...
(Date:7/24/2008)...ital facility on Sand Canyon Avenue , ...08 -- Hoag Memorial Hospital Presbyterian has reac...l Estate Investment Trust headquartered in Long Be... Sand Canyon Avenue near the 405 freeway in Irvine...d by Tenet Healthcare Corporation (NYSE: THC) as I...
(Date:7/24/2008)...stCall/ -- ev3 Inc. (Nasdaq:,EVVV) today announced...and,year-to-date financial results. ev3 will now r...ancial results on Monday, July 28, 2008, after reg... a conference call and webcast at 7:30 a.m.,Centra...9, 2008. ev3,management will review its second qua...
(Date:7/24/2008)...ine Annual Report Experience it at http:/...f., July 24 /PRNewswire/ -- Are you an e-patient?,...users go online for,health information. Thanks to ...re personal health experiences, shop for health ca...Go to http://SutterHealth.org/annualreport ,and y...
Breaking Medicine News(10 mins):Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2Health News:ev3 Inc. Announces Revised Date for 2008 Second Quarter Financial Results and Conference Call 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 3Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 4
...edouble its efforts in the fight against HIV and A...tions program on HIV/AIDS, comes after Fiji's Mini...e in the number of people living with HIV and AIDS... The figures show that there were 36 new cases in...
...zil, Paraguay and Bolivia after an outbreak of den...fall //this season as a cause of the unusually rap...ncommonly warm weather has boosted the population ...the disease. Globally, it infects 50 million peo...
...Ministry of Health reported 789 suspected cases in...he country. // Ouargaye district has an attack rat...istricts, Banfora, Batie and Sapouy are in the ale...specimens have tested positive for Neisseria menin...
...als in the brain of mice were augmented, condition...ate in such animals. //This was reported by resear...alifornia. This finding could throw light in the ...cording to this study published in Nature, a combi...
Other Medicine News:
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
...w Binding, Graduated Pipet Tips - 0.5l - 10 L. Des... and protein binding. Non-reactive. Beveled and re...tion. RNAse & DNAse free. AVR100S is the Sterile R...0 is the Cell Rack packaged 96 tips/rack and 10 ra...
Packed conveniently in plastic-wrapped racks of 96 tips, Sterilized Diamond- Tips are ready to useno need to autoclave. Sterilized Diamond Tips are irradiated by gamma-rays for more efficient sterili
Like all Gilson disposable pipette tips, TowerPacks are available in a sterilized version. Each Sterilized TowerPack is individually wrapped in medical device-quality plastic to help protect tips fro
Medicine Products: